Study Finds Yaz, Yasmin, Similar Contraceptives Carry Higher Blood Clot Risk
Birth control pills like Yasmin, Yaz, Ocella, Gianvi and Zarah, all of which contain a synthetic form of progestin called drospirenone, may pose a higher risk of blood clots compared to oral...
View ArticleYaz Lawsuit Claims Birth Control Pill Caused Fatal Blood Clot
A grieving mother is blaming the Yaz birth control pill for her daughter’s death. Joan Cummins of Hackettstown, New Jersey, has filed a wrongful death lawsuit against Bayer Corporation, the maker of...
View ArticleYasmin Advertisement Misleading, British Regulatory Body Says
Bayer is in trouble over advertising for its Yasmin birth control pill. According to a report from the Financial Times, a British regulatory authority says Bayer has promoted Yasmin for uses that have...
View ArticleYaz, Yasmin, Similar Birth Control Pills in FDA Spotlight over Blood Clots
The U.S. Food & Drug Administration (FDA) announced today that it is evaluating the safety of birth control pills, such as Yaz and Yasmin, that contain a synthetic form of progestin called...
View ArticleLawsuit Claims Yasmin, Ocella Caused Teen to Suffer Fatal Pulmonary Embolism
A new lawsuit claims the birth control pills Yasmin and Ocella caused the death of a 15-year-old North Carolina girl from a pulmonary embolism. According to the complaint, which was filed in Buncombe...
View ArticleAs Yaz, Yasmin Safety Worries Mount, So Do Lawsuits
The litigation involving Bayer’s Yaz and Yasmin birth control pills continues to grow. According to a report from NJ.com, hundreds of lawsuits claiming Yaz and Yasmin caused young women to suffer blood...
View ArticleYaz, Yasmin Judge Promises to Push for Settlement Next Year, After First Test...
Once the initial test, or bellwether, trials are completed in the federal Yaz and Yasmin litigation, the judge overseeing the lawsuits says he will push the parties to reach a settlement. In a order...
View ArticleFDA Says Yaz, Yasmin Blood Clot Risk Still a Concern
U.S. health regulators are still worried about the potential for blood clots posed by drospirenone-containing birth control pills like Yaz and Yasmin. In a Drug Safety Communication posted on its...
View ArticleFDA Advisory Panel to Take Up Yaz, Yasmin
The U.S. Food and Drug Administration (FDA) recently sought assistance in its review of Bayer’s Yaz and Yasmin birth control pill line of medications. The advisory panel is scheduled to convene this...
View ArticleStudy Confirms Birth Control Pills with Drospirenone, Other New Progestins,...
A new study in the British Medical Journal confirms that birth control pills containing newer, synthetic progestins – such as Yaz and Yasmin, which are made with drospirenone – pose an increased risk...
View ArticleYaz, Yasmin Blood Clot Risk Reported in Israeli Study
Yet another study has confirmed that birth control pills like Yaz and Yasmin are more likely to cause blood clots compared to other oral contraceptives. This latest study, which involved 330,000...
View ArticleYaz, Yasmin Documents Show Bayer May Have Hidden Risk, Promoted Unapproved Uses
A new report says Bayer AG may have considered marketing the Yaz birth control pills for off-label uses. According to a report from Bloomberg, company documents uncovered in the course of Yaz and...
View ArticleFirst Individual Yasmin Lawsuit Filed In Canada
The first individual Yasmin lawsuit has been filed in Canada by the family of a 26-year-old woman who died after taking the birth control pills. Vicky Caprice Mersereau died of a large pulmonary...
View ArticleStronger Yaz, Yasmin Blood Clot Warnings May be Warranted, FDA Says
Yaz, Yasmin and similar birth control pills could soon bear stronger warnings regarding their association with a higher risk of blood clots. According to a report from Reuters, U.S. Food & Drug...
View ArticleFDA Panel Backs Stronger Yaz, Yasmin Blood Clot Warnings
The labels for Yaz, Yasmin and other birth control pills made with drospirenone, a synthetic form of progestin, should bear stronger warnings about their possible potential to cause serious, life...
View ArticleFirst Yaz, Yasmin Test Trial Postponed, as Lawsuits Head to Mediation
The first bellwether trial in the federal Yaz and Yasmin product liability litigation has been postponed. According to a report from FiercePharma, U.S. District Court Judge David Herndon, who is...
View ArticleFDA Advisors who Backed Yaz, Yasmin had Ties to Bayer
Several of the outside experts who recently made safety recommendations for Yaz, Yasmin and other drospirenone birth control pills had ties to Bayer AG, the maker of the drugs. However, those ties were...
View ArticleNew FDA Yaz, Yasmin Hearing Sought Amid Conflict-of-Interest Concerns
A public advocacy group wants the U.S. Food & Drug Administration (FDA) to convene another advisory panel hearing on the safety of Yaz, Yasmin and other birth control pills containing the synthetic...
View ArticleLawyers for Yaz, Yasmin Plaintiffs want to Present Evidence on FDA Conflicts
Lawyers representing thousands of women injured by the oral contraceptives Yaz or Yasmin have asked a federal judge overseeing consolidated litigation to not dismiss key evidence showing...
View ArticleHealth Concerns and Litigation over Yaz/Yasmin Birth Control
Bayer is being widely criticized over Yaz and Yasmin, two similar types of oral contraceptives. The popular birth control pills are reportedly responsible for causing blood-clots, with some instances...
View Article
